Abstract:Abstract Background In preclinical human Alzheimer’s disease (AD), novelty‐related functional connectivity of the locus coeruleus (LC) with the medial temporal lobe (MTL) (Conn LC‐MTL ) predicted beta‐amyloid (Aβ)‐related longitudinal cognitive decline. In animals, LC lesions in AD models led to dwindling LC projections to the hippocampus, hippocampal atrophy, and cognitive impairment. Following these observations, we investigated the contribution of cross‐sectional and longitudinal atrophy in early Braak stages as a potential mechanism underlying this relationship. Method We included 128 participants of the Harvard Aging Brain Study (HABS) with baseline Pittsburgh Compound‐B Positron Emission Tomography – Distribution Volume Ratio (PiB PET, DVR; 36 Aβ+), as well as baseline functional and longitudinal structural MRI (n tot = 372; ∼ every 3 years; follow‐up 5±3.4 years) and yearly cognitive assessments (PACC5 = Preclinical Alzheimer’s Cognitive Composite; n tot = 874; follow‐up 6.5±3.3 years) (Table 1). Conn LC‐MTL values were derived voxel‐wise and averaged across significant clusters. FreeSurfer‐estimated cortical thickness and hippocampus/amygdala volume (adjusted for intracranial volume) were z‐scored and averaged in two variables (THV 2 /THV 3 ), encompassing regions associated with Braak stage II and III respectively (Table 1). Baseline associations were evaluated with linear models, longitudinal relationships between Conn LC‐MTL and THV 2 /THV 3 with mixed‐effects models (random intercept and slope). Mediation of Conn LC‐MTL and PACC5 slopes (year 5‐13) by THV 2 /THV 3 slopes (year 0‐5) was calculated (n = 79; bootstrapped n = 1000; Table 1). All models contained age, sex and education as covariates. Result At baseline, Conn LC‐MTL positively associated with THV 2 (p = 0.005) and with PACC5 (p = 0.045), but not with THV 3 (p = 0.26; Figure 1A‐C). Longitudinally, Conn LC‐MTL did not predict changes in THV 2 nor THV 3 . However, we observed faster cortical atrophy with lower Conn LC‐MTL at higher levels of neocortical PiB (THV 2 : p = 0.02; THV 3 : p<0.001; Figure 1D‐E). Finally, THV 2 , but not THV 3 , mediated the relationship between Conn LC‐MTL and PACC5 decline (p = 0.024) and this effect was stronger in PiB+ individuals compared to PiB‐ (p = 0.026; Figure 2). Conclusion Worse LC‐MTL connectivity was associated with downstream atrophy in the target Braak‐stage II areas, which impacted cognitive performance in preclinical AD. Given that in similar previous animal findings activation of the norepinephrine LC system reversed memory deficits, maintaining optimal Conn LC‐MTL may be a promising intervention target to delay disease progression.

Locus coeruleus tau is linked to successive cortical tau accumulation

Spatiotemporal Assessment of Locus Coeruleus Integrity Predicting Cortical Tau and Cognition

Locus coeruleus metabolic changes as a predictor of tau accumulation and cognitive decline

Locus coeruleus vulnerability to tau hyperphosphorylation in a rat model

Lower novelty‐related locus coeruleus function is associated with entorhinal tau‐mediated memory decline in older individuals.

Association of Novelty-Related Locus Coeruleus Function With Entorhinal Tau Deposition and Memory Decline in Preclinical Alzheimer Disease

Atrophy links lower novelty‐related locus coeruleus connectivity to cognitive decline in preclinical AD

Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC’s afferent and efferent connections

Changes in the locus coeruleus during the course of Alzheimer's disease and their relationship to cortical pathology

Sparse Asymmetry in Locus Coeruleus Pathology in Alzheimer's Disease

Braak‐stage II atrophy links lower locus coeruleus – medial temporal lobe connectivity to cognitive decline in preclinical AD

Remote Associations Between Tau and Cortical Amyloid-β Are Stage-Dependent

Consequences of Pathogenic Tau Expression in Mouse Locus Coeruleus

Lower Locus Coeruleus Integrity Signals Elevated Entorhinal Tau and Clinical Progression in Asymptomatic Older Individuals

Global neuropathologic severity of Alzheimer's disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels

Global amyloid burden enhances network efficiency of tau propagation in the brain

In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer’s disease pathology and cognitive decline

Initial Levels of Β-Amyloid and Tau Deposition Have Distinct Effects on Longitudinal Tau Accumulation in Alzheimer’s Disease

Lower novelty-related locus coeruleus function is associated with Aβ-related cognitive decline in clinically healthy individuals

Altered structural covariance of locus coeruleus in individuals with significant memory concern and patients with mild cognitive impairment

Locus coeruleus in memory formation and Alzheimer's disease